Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC)1 and OXB,1 today announce the start of LENTICLAIRTM 1, a Phase I/II trial ...

Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

Researchers from Heidelberg University, Heidelberg University Hospital (UKHD) and Heidelberg Institute for Theoretical ...

Researchers developed a pyrene coating for graphene membranes, addressing delamination and enhancing device performance in ...

Observational studies are critical tools in clinical research and public health response, but challenges arise in ensuring ...

This important study focused on characterizing clonally derived MSC populations from the synovium of normal and osteoarthritis (OA) patients, demonstrating their potential to regenerate cartilage in ...

Lead researcher Dr Andres Gambini explains kangaroos were chosen for IVF because of their abundant population. Photo shows New Year's Weather: Dark grey storm clouds over a green forested area ...

Similarly in urine, PBMCs from AAV patients produced less soluble PD-1, even in response to stimulation with MPO ... in order to facilitate a comparison of the mechanical properties of soluble and ...

Seven-transmembrane segment ... with plasmids expressing secreted gp120 from HIV-1 strains ADA and HXBc2. The medium was replaced 24 h after the transfection with labeling medium, as described ...

6 Department of Internal Medicine, Teaching Hospital Amiens, Picardie Jules Verne University, Amiens, France Correspondence to Dr Claire Andréjak, Department of Respiratory Diseases, Teaching Hospital ...